HCA Healthcare
HCA · What the business does, what can go wrong, and how options sellers approach it
What it does
HCA Healthcare owns and operates hospitals and related outpatient facilities. It operates a large network of for-profit hospitals in the United States. Its facilities include acute-care hospitals, emergency rooms, surgery centers, urgent care clinics and physician practices, concentrated in several U.S. states, with a small presence in the United Kingdom.
How it makes money
HCA earns revenue when patients receive care. Payers include commercial insurers, government programs such as Medicare and Medicaid, and patients themselves. Revenue depends on how many patients are treated (admissions, surgeries, emergency visits) and on the rates negotiated with each payer. Commercial insurers generally pay more than government programs, so the payer mix matters for profit. Major costs include nurses and other staff, supplies, and the upkeep of facilities.
Why investors own it
- Scale: A large network can negotiate with insurers and suppliers and spread fixed costs across many facilities.
- Local density: Clusters of hospitals and outpatient sites in the same markets can send patients through connected services.
- Steady demand: Healthcare use tends to hold up better than many other spending categories, though not perfectly.
- Capital returns: The company has historically returned cash through buybacks and dividends, which are not guaranteed.
What can go wrong
- Government payment rates or healthcare policy can change, such as Medicare and Medicaid reimbursement or insurance subsidies.
- Insurers may push back on rates, or the mix of insured patients may shift.
- Labor shortages and wage pressure can raise costs quickly.
- Debt is a meaningful part of the capital structure, so rising interest rates or weaker earnings can matter more.
- Legal, regulatory and quality-of-care issues can lead to fines or reputational damage.
What to watch
- Admissions and same-facility volume trends
- Payer mix, especially the share of insured patients
- Revenue per admission
- Labor costs and contract labor use
- Operating margins
- Government payment rule updates
- Debt levels and share repurchase activity
Options income angle
Options on HCA are generally liquid, especially near-the-money contracts in the nearest expirations, though spreads can be wider in longer-dated or far out-of-the-money strikes. Implied volatility tends to rise ahead of quarterly earnings and around policy news affecting hospital reimbursement or insurance coverage. One caution for premium sellers: a sharp move after earnings or a policy announcement can quickly overwhelm the premium collected, so position size and the possibility of assignment deserve careful thought.
What the latest 10-K says
A plain-English read of the Risk Factors and Management's Discussion in the 10-K for the year ended December 31, 2025, filed February 10, 2026. Figures are as the filing reports them. Read the filing on SEC.gov
The filing in brief
HCA Healthcare grew revenues to $75.600 billion in 2025 and net income attributable to the company to $6.784 billion. It also carries total indebtedness of $46.492 billion. The filing expects 2026 to be pressured by the expiration of enhanced premium tax credits and by Medicaid payment changes under the 2025 Federal Budget Act (the "FBA"). Florida and Texas produce 51% of revenues.
How the business did
- Revenues rose 7.1% to $75.600 billion from $70.603 billion. Management credits a 2.9% increase in equivalent admissions (a measure that blends inpatient and outpatient volume) and a 4.0% increase in revenue per equivalent admission.
- Net income attributable to the company was $6.784 billion, or $28.33 per diluted share, against $5.760 billion, or $22.00. The 2024 results absorbed roughly $250 million of expenses and lost revenue from Hurricanes Helene and Milton. Salaries and benefits fell to 43.5% of revenues from 44.1%.
- Cash provided by operating activities was $12.636 billion, up from $10.514 billion. The company paid $10.067 billion for share repurchases and $679 million in dividends, and spent $4.944 billion on capital expenditures.
- Interest expense rose to $2.248 billion from $2.061 billion on a higher average debt balance. Supply costs per equivalent admission rose 7.0% for medical devices. Outpatient surgical volumes declined 0.2%.
Risks specific to this company
- Debt: Total indebtedness was $46.492 billion, with $2.507 billion at variable rates. The credit facility requires a specified financial ratio, and a breach could let lenders demand immediate repayment, which would trigger defaults on much of the other debt.
- Government payers: Medicare and Medicaid supplied 45.4% of revenues. The FBA limits Medicaid state directed payments (extra payments states route through managed care plans) by tying caps to Medicare rates, a change the filing expects to affect Texas among other states.
- Coverage losses: The enhanced premium tax credits for insurance marketplaces expired at the end of 2025. The company expects lower marketplace enrollment and a higher uninsured rate. The estimated cost of uncompensated care was $4.605 billion in 2025, compared with $4.366 billion in 2024.
- Geographic concentration: Of 190 hospitals, 102 are in Florida and Texas. Hurricanes are a named exposure, and property insurance covers claims above deductibles generally at $110 million per occurrence.
- Labor: Nurse shortages, union activity and state staffing-ratio laws can raise costs. Much of revenue comes from rates that are fixed or renegotiated at least annually, which limits how fast costs can be passed on.
- Systems change: The company is rolling out a new electronic health record platform across its facilities. The filing says delays could add expense and divert management attention.
What management is watching
- 2026 pressure: Excluding any additional approvals, state directed payment revenue is expected to decline in 2026 from 2025. Marketplace reforms and the credit expiration are expected to hurt 2026 results, partly offset by resiliency efforts (cost and efficiency initiatives). Inflation is expected to keep pushing up operating expenses.
- Spending: Planned capital expenditures are between $5.0 billion and $5.5 billion in 2026. Projects under construction need about $7.1 billion more over five years.
- Capital return: The Board authorized $10 billion for repurchases in January 2026, and $750 million remained under the January 2025 authorization at year-end. It declared a quarterly dividend of $0.78 per share on January 26, 2026.
- Technology: Management is investing in digital, data and artificial intelligence tools to improve quality and efficiency, while noting that the benefits are uncertain.
- Metrics: Management points to admissions, equivalent admissions, revenue per equivalent admission, same facility results and days revenues in accounts receivable, which was 51.
What the latest 10-Q says
A plain-English read of Management's Discussion (and any new or changed risk factors) in the 10-Q for the quarter ended September 30, 2026, filed October 29, 2026. Figures are as the filing reports them. Read the filing on SEC.gov
The quarter in brief
HCA Healthcare grew revenues to $19.849 billion from $19.161 billion, but net income attributable to the company fell to $1.579 billion from $1.643 billion. Uninsured admissions rose 27.2% on a consolidated basis, which the company ties to the end of enhanced premium tax credits (EPTCs, subsidies for insurance bought on the health exchanges) and administrative reforms. Earnings per diluted share still rose to $7.27 from $6.96, because the diluted share count fell to 217.212 million from 236.181 million.
How the business did
- Revenue and profit: Revenues rose 3.6% for the quarter, driven by a 2.8% increase in equivalent admissions (a measure combining inpatient and outpatient volume) and a 0.7% increase in revenue per equivalent admission. Income before income taxes was $2,370 million versus $2,418 million. For nine months, revenues rose 5.5% to $59.188 billion, while net income attributable to the company was $4.898 billion versus $4.906 billion.
- Costs: Other operating expenses were 23.0% of revenues versus 21.8%. Salaries and benefits were 43.2% versus 43.6%, and supplies were 14.2% versus 14.5%. Estimated uncompensated care cost (charity care, uninsured discounts and uncollectible amounts) was $1.477 billion versus $1.188 billion.
- Volumes: Emergency department visits rose 5.3%, while inpatient surgeries fell 1.3% and outpatient surgeries fell 4.2%. Managed care and insurers revenue was unfavorably affected by the EPTC expiration. Nine-month Medicaid revenue was helped by approved state directed payment programs, mainly in Florida.
- Cash and capital: Operating cash flow was $4.461 billion for the quarter versus $4.416 billion. For nine months it was $8.810 billion versus $10.277 billion, which the company attributes mainly to higher income taxes paid after a 2025 IRS payment deferral and to working capital changes. Nine-month share repurchases were $6.605 billion and dividends were $519 million. Debt totaled $50.493 billion.
What management is watching
- Spending: Planned 2026 capital expenditures are between $5.0 billion and $5.5 billion, excluding acquisitions. Projects under construction have estimated additional costs of approximately $8.6 billion over the next five years.
- Medicaid policy: The 2025 Federal Budget Act ties caps on state directed payments to Medicare rates, with a phase-down for grandfathered arrangements starting in 2028. Further approvals at the higher commercial rate could add revenue that "may be significant," but the company says it cannot predict their timing or size. A July 2026 CMS proposed rule on provider taxes adds uncertainty, and the company cannot predict its impact.
- Costs and offsets: Management expects inflation to keep pressuring operating expenses and points to its resiliency initiatives, which aim to improve efficiency and cut costs to offset policy changes.
- Funding: The commercial paper program (short-term borrowing) was raised to $8.000 billion from $4.000 billion. Working capital was negative $3.560 billion, which the company ties to short-term borrowings and debt due within one year. It says it can refinance the commercial paper through its credit facility. Management believes cash flow, the credit facility and debt markets will meet liquidity needs.
Follow HCA in Kortex
The Kortex app shows HCA's price, options chain and IV rank, and answers your questions from live market data and SEC filings.
Free to download.
Learn the strategies
More stock briefs
For education only, not financial advice. Options involve risk and are not suitable for every investor.